Mark Iwicki Email

CEO . Inhibikase Therapeutics

ATLANTA, GA

Location

LinkedIn

Current Roles

Employees:
8
Revenue:
$804k
About
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson's disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.
Inhibikase Therapeutics Address
3350 Riverwood Parkway
ATLANTA, GA
United States
Inhibikase Therapeutics Email
Inhibikase Therapeutics Phone Numbers
678-392-3419